Expert consensus: Renal denervation for the treatment of arterial hypertension
Archives of cardiovascular diseases2012Vol. 105(6-7), pp. 386–393
Citations Over TimeTop 10% of 2012 papers
Atul Pathak, Xavier Girerd, Michel Azizi, Hakim Benamer, Jean‐Michel Halimi, Pierre Lantelme, Thierry Lefèvre, Marc Sapoval
Related Papers
- → Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial(2021)139 cited
- → Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements(2023)28 cited
- → Renal sympathetic denervation: effect on ambulatory blood pressure and blood pressure variability in patients with treatment-resistant hypertension. The ReShape CV-risk study(2015)18 cited
- → One-year outcomes of percutaneous renal denervation for the treatment of resistant hypertension: the first Chinese experience(2014)1 cited
- → Unilateral renal sympathetic denervation may reduce blood pressure in patients with refractory hypertension(2015)